---
title: "Hepatitis E Virus IgG Seropositivity and Kidney Dysfunction in US Adults"
id: "medrxiv-3-hepatitis-e-virus-immunoglobulin-g-seropositivity-and-kidney-dysfunction-among"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-3-hepatitis-e-virus-immunoglobulin-g-seropositivity-and-kidney-dysfunction-among"
content_type: "clinical_feed_article"
specialty: "Nephrology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.15.26363188v1?rss=1"
published_at: "2026-09-18T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Hepatitis E Virus IgG Seropositivity and Kidney Dysfunction in US Adults
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-3-hepatitis-e-virus-immunoglobulin-g-seropositivity-and-kidney-dysfunction-among
- **Specialty:** [Nephrology](https://medichelpline.com/clinical-feed/nephrology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.15.26363188v1?rss=1)
- **Published At:** 2026-09-18T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This cross-sectional analysis used six NHANES cycles (2009–2018 and August 2021–August 2023) to examine associations between **Hepatitis E virus** immunoglobulin G seropositivity and markers of kidney dysfunction in US adults aged ≥20 years. - The analytic sample included 30,428 adults with valid hepatitis E IgG, serum creatinine, urinary albumin-to-creatinine ratio (ACR), and covariate data; 2,911 participants were seropositive, yielding a weighted seroprevalence of **8.29%**. - Seropositive participants were older than seronegative participants (weighted mean age 60.7 vs 46.5 years). - Binary kidney outcomes were defined as reduced estimated glomerular filtration rate (**eGFR** <60 mL/min/1.73 m2), **albuminuria** (ACR ≥30 mg/g), and a composite of these outcomes. - In unadjusted survey-weighted logistic regression, seropositivity was associated with all three binary outcomes; however, associations attenuated after adjustment for age and sex and further in fully adjusted models. - Fully adjusted odds ratios were 0.99 (95% CI, 0.85–1.16) for reduced eGFR, 1.05 (95% CI, 0.91–1.22) for albuminuria, and 1.05 (95% CI, 0.93–1.19) for the composite outcome, indicating no significant association after adjustment. - In a secondary analysis using continuous eGFR, seropositivity was associated with a 1.57 mL/min/1.73 m2 higher adjusted mean eGFR (95% CI, 0.71–2.43). - The authors emphasize that adjustment, particularly for age and sex, attenuated associations; the findings do not rule out effects during active or persistent infection and do not establish absence of any association. - The study used publicly available NHANES data approved by the NCHS Research Ethics Review Board; the present analysis did not require additional IRB approval. Authors declared no competing interests.
## Clinical Analysis & Structured Key Points
Hepatitis E virus immunoglobulin G seropositivity and kidney dysfunction among United States adults | medRxiv Skip to main content Hepatitis E virus immunoglobulin G seropositivity and kidney dysfunction among United States adults Alara Abu Saadeh , Houssam Eddine Youcefi , View ORCID Profile Mohamad Ali Kalaji , Layla Alkhuder , View ORCID Profile Yaman Alsukari , Mahmoud Alothman Agha , View ORCID Profile Anas Sermani doi: https://doi.org/10.64898/2026.09.15.26363188 Alara Abu Saadeh 1 Bahcesehir Universitesi; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Houssam Eddine Youcefi 1 Bahcesehir Universitesi; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Mohamad Ali Kalaji 2 American University of Beirut; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Mohamad Ali Kalaji Layla Alkhuder 2 American University of Beirut; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Yaman Alsukari 3 Damascus Hospital; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Yaman Alsukari Mahmoud Alothman Agha 4 RAK Medical and Health Sciences University: Ras Al Khaimah Medical and Health Sciences University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Anas Sermani 5 Ankara Yildirim Beyazit Universitesi Tip Fakultesi Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Anas Sermani For correspondence: anasmaamoun{at}gmail.com Abstract Info/History Metrics Data/Code Preview PDF Abstract Background Hepatitis E virus infection is associated with renal manifestations in selected clinical populations. Whether serologic evidence of previous exposure is associated with kidney dysfunction in the general population remains uncertain. Methods We conducted a cross-sectional analysis of six National Health and Nutrition Examination Survey cycles from 2009–2018 and August 2021–August 2023. Adults aged ≥20 years with valid hepatitis E virus immunoglobulin G levels, serum creatinine levels, urinary albumin-to-creatinine ratios, and covariate data were included. The outcomes included a reduced estimated glomerular filtration rate (<60 mL/min/1.73 m2), albuminuria (albumin-to-creatinine ratio ≥30 mg/g [3.39 mg/mmol]), and their composite. Survey-weighted logistic regression models were unadjusted, adjusted for age and sex, and additionally adjusted for demographic and clinical covariates. Results Among 30,428 adults, 2,911 were seropositive; the weighted seroprevalence was 8.29%. The seropositive participants were older than the seronegative participants were (weighted mean, 60.7 versus 46.5 years). Seropositivity was associated with all three binary outcomes in unadjusted analyses, but the estimates approached the null after adjustment for age and sex. The fully adjusted odds ratios were 0.99 (95% confidence interval, 0.85–1.16) for a reduced filtration rate, 1.05 (0.91–1.22) for albuminuria, and 1.05 (0.93–1.19) for composite kidney dysfunction. In a secondary analysis, seropositivity was associated with a 1.57 mL/min/1.73 m2 higher adjusted mean filtration rate (95% confidence interval, 0.71–2.43). Conclusions Hepatitis E virus immunoglobulin G seropositivity was not significantly associated with binary kidney outcomes after adjustment. Attenuation occurred principally after adjustment for age and sex. These findings do not establish the absence of an association and do not address kidney injury during active or persistent infection. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Not Applicable The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The NHANES protocols were approved by the National Center for Health Statistics (NCHS) Research Ethics Review Board, and written informed consent was obtained from all participants. The present study used de-identified, publicly available NHANES data and therefore did not require additional institutional review board approval. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Not Applicable I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Not Applicable I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Not Applicable Data Availability No data were generated by this study. The study used publicly available data from the National Health and Nutrition Examination Survey (NHANES), provided by the National Center for Health Statistics, Centers for Disease Control and Prevention. NHANES datasets and associated documentation are publicly available from the CDC/NCHS NHANES website (https://www.cdc.gov/nchs/nhanes/). https://www.cdc.gov/nchs/nhanes/ Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted September 18, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Hepatitis E virus immunoglobulin G seropositivity and kidney dysfunction among United States adults Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Hepatitis E virus immunoglobulin G seropositivity and kidney dysfunction among United States adults Alara Abu Saadeh , Houssam Eddine Youcefi , Mohamad Ali Kalaji , Layla Alkhuder , Yaman Alsukari , Mahmoud Alothman Agha , Anas Sermani medRxiv 2026.09.15.26363188; doi: https://doi.org/10.64898/2026.09.15.26363188 Share This Article: Copy Citation Tools Hepatitis E virus immunoglobulin G seropositivity and kidney dysfunction among United States adults Alara Abu Saadeh , Houssam Eddine Youcefi , Mohamad Ali Kalaji , Layla Alkhuder , Yaman Alsukari , Mahmoud Alothman Agha , Anas Sermani medRxiv 2026.09.15.26363188; doi: https://doi.org/10.64898/2026.09.15.26363188 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Nephrology Subject Areas All Articles Addiction Medicine (618) Allergy and Immunology (903) Anesthesia (334) Cardiovascular Medicine (4823) Dentistry and Oral Medicine (479) Dermatology (416) Emergency Medicine (650) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1632) Epidemiology (15966) Forensic Medicine (33) Gastroenterology (1205) Genetic and Genomic Medicine (7058) Geriatric Medicine (733) Health Economics (1066) Health Informatics (5054) Health Policy (1436) Health Systems and Quality Improvement (1774) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16300) Intensive Care and Critical Care Medicine (1174) Medical Education (671) Medical Ethics (155) Nephrology (726) Neurology (7288) Nursing (368) Nutrition (1082) Obstetrics and Gynecology (1243) Occupational and Environmental Health (1005) Oncology (3613) Ophthalmology (1054) Orthopedics (398) Otolaryngology (457) Pain Medicine (472) Palliative Medicine (139) Pathology (709) Pediatrics (1805) Pharmacology and Therapeutics (737) Primary Care Research (768) Psychiatry and Clinical Psychology (5911) Public and Global Health (9768) Radiology and Imaging (2429) Rehabilitation Medicine and Physical Therapy (1455) Respiratory Medicine (1249) Rheumatology (642) Sexual and Reproductive Health (773) Sports Medicine (578) Surgery (780) Toxicology (107) Transplantation (305) Urology (292)
## Related Clinical Research

- [Low antenatal hepatitis B testing and incomplete infant birth‑dose coverage in Nigeria’s MTCT prev](https://medichelpline.com/clinical-feed/medrxiv-6-contact-without-protection-high-antenatal-attendance-minimal-hepatitis-b.md)
- [Kennedy renews attacks on vaccines at Children’s Health Defense conference](https://medichelpline.com/clinical-feed/stat-news-1-kennedy-renews-attacks-on-vaccines-at-children-s-health-defense-conference.md)
- [IeDEA 2026 Site Assessment: Protocol for a Cross-Sectional Survey of HIV Clinics and Service Deliv](https://medichelpline.com/clinical-feed/medrxiv-12-documenting-hiv-service-delivery-and-adoption-of-evidence-based-practices-in.md)
- [Serum Magnesium and Risk of Spontaneous Bacterial Peritonitis and Sepsis in Hospitalized Cirrhosis](https://medichelpline.com/clinical-feed/frontiers-in-immunology-19-association-of-serum-magnesium-levels-with-the-risk-of-spontaneous-bacterial.md)
- [Interventions to Improve Perinatal Care Access for Migrant Women Without Medical Insurance](https://medichelpline.com/clinical-feed/plos-one-18-interventions-facilitating-access-to-perinatal-care-for-migrant-women-without.md)

## Navigation
- [← Back to Nephrology Feed](https://medichelpline.com/clinical-feed/nephrology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.